SCHEMBL20166113

SCHEMBL20166113

CS(=O)(=O)N(c1nccc(N2CCC(C(=O)N3N=CCC3c3ccccc3)CC2)n1)S(C)(=O)=O

nearest known ligand 0.65

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 20/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20166112 1.00 RIPK1 (0.65) RIPK1
SCHEMBL20168839 0.89 RIPK1 (0.70) RIPK1
SCHEMBL20168843 0.89 RIPK1 (0.70) RIPK1
SCHEMBL20166533 0.83 RIPK1 (0.72) RIPK1
SCHEMBL20166200 0.83 RIPK1 (0.72) RIPK1
SCHEMBL20166197 0.83 RIPK1 (0.72) RIPK1
SCHEMBL20166531 0.83 RIPK1 (0.72) RIPK1
SCHEMBL20165943 0.82 RIPK1 (0.68) RIPK1
SCHEMBL20165818 0.82 RIPK1 (0.68) RIPK1
SCHEMBL20165946 0.82 RIPK1 (0.68) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3541813-A1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS GlaxoSmithKline Intellectual Property Development Limited (GB) 2019-09-25 EP disclosed
WO-2018092089-A1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2018-05-24 WO disclosed